Literature DB >> 22652603

Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway.

Wijnand K den Dekker1, Dennie Tempel, Ilze Bot, Erik A Biessen, Leo A Joosten, Mihai G Netea, Jos W M van der Meer, Caroline Cheng, Henricus J Duckers.   

Abstract

OBJECTIVE: Activated mast cells (MCs) release chymase, which can induce vascular smooth muscle cell (VSMC) apoptosis leading to plaque destabilization. Because the mechanism through which MCs release chymase in atherosclerosis is unknown, we studied whether MC-associated VSMC apoptosis is regulated by toll-like receptor 4 (TLR4) signaling. METHODS AND
RESULTS: Local recruitment and activation of MCs reduced VSMC content specifically in the cap region of vulnerable plaques in apolipoprotein E knockout mice. Cotreatment with the TLR4 antagonist Bartonella quintana lipopolysaccharide prevented this VSMC loss, suggesting an important role for TLR4 signaling in MC-induced VSMC apoptosis. Coculture of VSMCs with MCs activated by the TLR4 agonist Escherichia coli lipopolysaccharide increased VSMC apoptosis. Apoptosis was inhibited by TLR4 and chymase blockers, indicating that TLR4 signaling is involved in chymase release in MCs. This pathway was mediated via interleukin-6 because interleukin-6 promoted MC-associated VSMC apoptosis, which was inhibited by blocking chymase release. In addition, TLR4 activation in MCs induced interleukin-6 production, which was reduced by preincubation with either B. quintana lipopolysaccharide or an anti-TLR4 antibody.
CONCLUSIONS: We show that MCs promote VSMC apoptosis in vivo. In addition, TLR4 signaling is important in chymase release in MCs and, therefore, in plaque destabilization by regulating VSMC apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652603     DOI: 10.1161/ATVBAHA.112.250605

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.

Authors:  Jing Wang; Sara Sjöberg; Viviane Tia; Blandine Secco; Han Chen; Min Yang; Galina K Sukhova; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-06-07       Impact factor: 5.162

Review 2.  Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Nevena Jeremic; George H Kunkel; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

Review 3.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

Review 4.  Mast cells as effectors in atherosclerosis.

Authors:  Ilze Bot; Guo-Ping Shi; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-07       Impact factor: 8.311

5.  Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.

Authors:  Martine Bot; Saskia C A de Jager; Luke MacAleese; H Maxime Lagraauw; Theo J C van Berkel; Paul H A Quax; Johan Kuiper; Ron M A Heeren; Erik A L Biessen; Ilze Bot
Journal:  J Lipid Res       Date:  2013-02-10       Impact factor: 5.922

6.  Complement factor C5a induces atherosclerotic plaque disruptions.

Authors:  Anouk Wezel; Margreet R de Vries; H Maxime Lagraauw; Amanda C Foks; Johan Kuiper; Paul H A Quax; Ilze Bot
Journal:  J Cell Mol Med       Date:  2014-08-15       Impact factor: 5.310

7.  Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response.

Authors:  Anouk Wezel; Margreet R de Vries; Johanna M Maassen; Peter Kip; Erna A Peters; Jacco C Karper; Johan Kuiper; Ilze Bot; Paul H A Quax
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

8.  IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms.

Authors:  Jing Wang; Jes S Lindholt; Galina K Sukhova; Michael A Shi; Mingcan Xia; Han Chen; Meixiang Xiang; Aina He; Yi Wang; Na Xiong; Peter Libby; Jian-An Wang; Guo-Ping Shi
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

Review 9.  Atherosclerosis: a chronic inflammatory disease mediated by mast cells.

Authors:  Pio Conti; Yazdami Shaik-Dasthagirisaeb
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

Review 10.  Mast Cell: A Multi-Functional Master Cell.

Authors:  Melissa Krystel-Whittemore; Kottarappat N Dileepan; John G Wood
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.